ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement?

, &
American Journal of Bioethics 11 (3):11-13 (2011)
  Copy   BIBTEX

Abstract

(2011). ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement? The American Journal of Bioethics: Vol. 11, No. 3, pp. 11-13

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2010.546477

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Principles of early stopping of randomized trials for efficacy: A critique of equipoise and an alternative nonexploitation ethical framework.David Buchanan & Franklin G. Miller - 2005 - Kennedy Institute of Ethics Journal 15 (2):161-178.
Early Stopping of Clinical Trials: Charting the Ethical Terrain.Erik Malmqvist, Niklas Juth, Niels Lynöe & Gert Helgesson - 2011 - Kennedy Institute of Ethics Journal 21 (1):51-78.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
The epistemology and ethics of early stopping decisions in randomized controlled trials.Roger Stanev - 2012 - Dissertation, University of British Columbia
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Stopping rules and data monitoring in clinical trials.Roger Stanev - 2012 - In H. W. de Regt, S. Hartmann & S. Okasha (eds.), EPSA Philosophy of Science: Amsterdam 2009, The European Philosophy of Science Association Proceedings Vol. 1, 375-386. Springer. pp. 375--386.
A clinical trials manual from the Duke Clinical Research Institute: lessons from a horse named Jim.Margaret B. Liu - 2010 - Hoboken, NJ: Wiley-Blackwell. Edited by Kate Davis & Margaret B. Liu.
Tailor-made pharmacotherapy: Future developments and ethical challenges in the field of pharmacogenomics.Johannes Van Delden, Ineke Bolt, Annemarie Kalis, Jeroen Derijks & Hubert Leufkens - 2004 - Bioethics 18 (4):303–321.
Pulling the plug on clinical equipoise: A critique of Miller and Weijer.Fred Gifford - 2007 - Kennedy Institute of Ethics Journal 17 (3):203-226.
The Duty to Exclude: Excluding People at Undue Risk from Research.Charles Weijer & Abraham Fuks - unknown
Bayesian versus frequentist clinical trials.David Teira - 2011 - In Gifford Fred (ed.), Philosophy of Medicine. Amsterdam: Elsevier. pp. 255-297.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
The protection of patients' rights in clinical trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.

Analytics

Added to PP
2011-03-12

Downloads
42 (#370,011)

6 months
10 (#251,846)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Discussion of Paper by Korn and Freidlin.Janet Wittes - 2011 - American Journal of Bioethics 11 (3):13-14.
Discussion of Paper by Korn and Freidlin.Janet Wittes - 2011 - American Journal of Bioethics 11 (3):13-14.

Add more references